BioVie, Inc. (BIVI)
1.37
+0.03
(+2.24%)
USD |
NASDAQ |
Mar 03, 16:00
1.36
-0.01
(-0.73%)
After-Hours: 20:00
BioVie Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 22.67M |
| Alnylam Pharmaceuticals, Inc. | 45.32M |
| Savara, Inc. | -0.023M |
| BioMarin Pharmaceutical, Inc. | 3.157M |
| Imunon, Inc. | 4.963M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.438M |
| Free Cash Flow | -14.32M |
| Free Cash Flow Per Share (Quarterly) | -0.5603 |
| Free Cash Flow to Equity (Quarterly) | -4.420M |
| Free Cash Flow to Firm (Quarterly) | -4.432M |
| Free Cash Flow Yield | -124.6% |